These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3776468)

  • 1. Growth activity of tumors at different intracranial structures: immunohistochemical study with bromodeoxyuridine.
    Yoshimine T; Ushio Y; Hayakawa T; Takemoto O; Maruno M; Mogami H
    Acta Neuropathol; 1986; 71(1-2):15-8. PubMed ID: 3776468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical demonstration with anti-bromodeoxyuridine monoclonal antibody in experimental meningeal carcinomatosis model.
    Huang TY; Hwang SL; Howng SL
    Kaohsiung J Med Sci; 1997 Mar; 13(3):136-40. PubMed ID: 9109299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth activity of meningeal carcinomatosis--immunohistochemical study using anti-BrdU monoclonal antibody].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Huang TY; Kuroda R; Mogami H
    No To Shinkei; 1988 Feb; 40(2):127-31. PubMed ID: 3370164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postnatal cell proliferation in the rat cerebrum: immunohistochemical study with bromodeoxyuridine (BrdU)].
    Fujita T; Yoshimine T; Hayakawa T; Ushio Y; Takemoto O; Maruno M; Kano M; Mogami H
    No To Shinkei; 1988 Jul; 40(7):651-5. PubMed ID: 3066383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal ACNU against experimental leptomeningeal tumors.
    Huang TY; Howng SL
    Kaohsiung J Med Sci; 1997 Oct; 13(10):626-30. PubMed ID: 9385779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases.
    Paulus W; Jänisch W
    Acta Neuropathol; 1990; 80(6):635-41. PubMed ID: 1703384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Davis RL
    Cancer; 1986 Oct; 58(7):1466-72. PubMed ID: 2427189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ACNU against experimental brain tumor--immunohistochemical study using anti-BrdU monoclonal antibody].
    Izumoto S; Arita N; Ushio Y; Hayakawa T; Yoshimine T; Tzuu-Yuan H; Nagatani M; Oku Y; Mogami H
    No To Shinkei; 1988 Nov; 40(11):1095-9. PubMed ID: 3219244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain changes and survival of animals with tumors implanted in the brain.
    Gershbein LL; Benuck I; Shurrager PS
    Oncology; 1975; 31(1):1-16. PubMed ID: 1161258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
    Lee KS; Yang WI
    Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse leptomeningeal seeding from benign choroid plexus papilloma.
    Ortega-Martínez M; Cabezudo-Artero JM; Fernández-Portales I; Pimentel JJ; Gómez de Tejada R
    Acta Neurochir (Wien); 2007 Dec; 149(12):1229-36; discussion 1236-7. PubMed ID: 17924056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
    Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
    Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of lodgement site on the proliferation-kinetics of tumor cells.
    Kawaguchi T; Endo M; Yokoya S; Nakamura K
    Experientia; 1981 Apr; 37(4):414-5. PubMed ID: 7238829
    [No Abstract]   [Full Text] [Related]  

  • 14. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
    Morimura T; Kitz K; Budka H
    Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible use for immunohistochemical detection of cells in S-phase labeled by bromodeoxyuridine.
    Mokrý J; Nĕmecek S; Adler J; Pokorná P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(1-2):5-15. PubMed ID: 8165431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meningeal gliomatosis: development of experimental models].
    Yoshida T; Ushio Y; Hayakawa T; Arita N; Yamada K; Mogami H
    No Shinkei Geka; 1984 Sep; 12(10):1141-8. PubMed ID: 6504251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroid plexus carcinoma with meningeal carcinomatosis in a dog.
    Patnaik AK; Erlandson RA; Lieberman PH; Fenner WR; Prata RG
    Vet Pathol; 1980 May; 17(3):381-5. PubMed ID: 7368530
    [No Abstract]   [Full Text] [Related]  

  • 18. Flow cytometric measurement of cell cycle kinetics in rat Walker-256 carcinoma following in vivo and in vitro pulse labelling with bromodeoxyuridine.
    Fogt F; Wan J; O'Hara C; Bistrian BR; Blackburn GL; Istfan NW
    Cytometry; 1991; 12(1):33-41. PubMed ID: 1825629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local blood-to-tissue transport in Walker 256 metastatic brain tumors.
    Blasberg RG; Shapiro WR; Molnar P; Patlak CS; Fenstermacher JD
    J Neurooncol; 1984; 2(3):205-18. PubMed ID: 6502195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of carcinomatosis of the pia mater].
    Matyja E; Kida E; Piórek T
    Neuropatol Pol; 1985; 23(1):49-54. PubMed ID: 4033954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.